Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months | NEJM
Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study | The BMJ
Covid vaccines slash risk of infection, illness and death, UK studies find | Financial Times
Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December
Changing the UK COVID-19 vaccine dosing schedule - POST
Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021 | MMWR
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study | The BMJ
Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks — Connecticut, December 2020–February 2021 | MMWR
Care needed' after getting Covid vaccine - BBC News
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine | NEJM
Pfizer-BioNTech COVID-19 vaccine shows real-world efficacy, despite the circulation of B.1.1.7 variant
mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar | Nature Medicine
Effectiveness of Covid-19 Vaccines over a 9-Month Period in North Carolina | NEJM
Pfizer Covid vaccine is 95% effective, plans to submit to FDA in days
Danish study on the efficacy of Pfizer/BioNTech SARS-CoV-2 vaccine after first and second dose
Those Who Had COVID-19 May Only Need One Dose of Vaccine | Penn Medicine
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study | The BMJ
Who Didn't Get a Second Shingrix Shot? Implications for Multidose COVID-19 Vaccines | KFF
Evaluation of COVID-19 vaccination strategies with a delayed second dose | PLOS Biology
Could a single-dose vaccine strategy be more beneficial in COVID-19?
Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study | The BMJ
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK - The Lancet
Covid-19: Pfizer/BioNTech vaccine judged safe for use in UK - BBC News
Pfizer/BioNTech vaccine starts working 10 days after first dose, says FDA | Financial Times
